What does a genogram for a family with a father having two pathogenic CFTR mutations and a mother being a CFTR mutation carrier look like?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Genogram for a Family with a Father Having Two Pathogenic CFTR Mutations and a Mother Being a CFTR Mutation Carrier

A genogram for this family would show a 50% chance of affected children and a 50% chance of carrier children for each pregnancy, with no possibility of unaffected non-carrier children.

Basic Genogram Structure and Symbols

A genogram for this family should include:

  • Standard symbols: squares for males, circles for females
  • Horizontal line connecting parents (marriage/relationship line)
  • Vertical line from parents to children
  • Special genetic notation for cystic fibrosis status

Parental Representation

  • Father: Square symbol with complete shading or double outline to indicate affected status (two pathogenic CFTR mutations)
  • Mother: Circle symbol with half shading or diagonal line to indicate carrier status (one pathogenic CFTR mutation)

Children Representation

Based on Mendelian inheritance patterns for this autosomal recessive condition:

  • Affected children (25% chance): Squares/circles with complete shading or double outline
  • Carrier children (50% chance): Squares/circles with half shading or diagonal line
  • Unaffected non-carriers (25% chance): Not possible in this scenario - all children will either be affected or carriers

Genetic Inheritance Pattern

The inheritance pattern in this case is unique because:

  1. The father has two pathogenic CFTR mutations (genotype: mut/mut)
  2. The mother is a carrier with one pathogenic mutation (genotype: mut/wt)
  3. The father can only contribute a mutated CFTR allele to offspring
  4. The mother has a 50% chance of contributing either her normal or mutated allele

Therefore, each child will have either:

  • Genotype mut/mut (affected with CF) - 50% probability
  • Genotype mut/wt (carrier) - 50% probability

Additional Genogram Elements

For a comprehensive clinical genogram, include:

  • Ages of individuals
  • Specific CFTR mutations when known (e.g., F508del, G542X, etc.)
  • Health status indicators for affected individuals
  • Three-generation pedigree including grandparents if possible 1
  • Dates of birth, diagnosis, and death (if applicable)

Clinical Implications

This genetic scenario has significant implications:

  • All children will either have CF or be carriers
  • No possibility of unaffected non-carrier children
  • Each pregnancy has a 50% risk of producing a child with CF
  • Genetic counseling is essential for this family 2
  • Prenatal testing options should be discussed

Common Pitfalls to Avoid

  • Failing to distinguish between different types of CFTR mutations, which can affect disease severity
  • Not accounting for the father's CF status in reproductive counseling
  • Overlooking the need for genetic counseling for carrier children as they reach reproductive age
  • Neglecting to update the genogram as classification of CFTR variants evolves 2

This genogram serves as a valuable tool for genetic counseling, family planning, and medical management in this family with significant CF genetic burden 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cystic Fibrosis Genetic Counseling and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The use of the genogram in palliative care.

Palliative medicine, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.